scholarly journals Surgical Treatment of Bilateral Optic Nerve Sheath Meningioma: 2-Dimensional Operative Video

2021 ◽  
Author(s):  
Marcio S Rassi ◽  
Ossama Al-Mefty

Abstract Even though intracranial meningiomas commonly invade the optic canals, true optic nerve sheath meningiomas are extremely rare. They are insidious lesions that frequently grow in 4 stages, leading to progressive visual loss.1–4  Frequently, management includes observation for asymptomatic patients, and fractioned stereotactic radiotherapy with progressive visual loss.1,3 However, surgery is avoided due to the risk of perioperative visual loss.2–4  However, many of these cases present in the early stage of tumor growth, where an arachnoidal plane is still present, and vision can be saved by microsurgical tumor resection.2 Here we present the case of a 33-yr-old female presenting with a 3-wk history of blurred vision. Neuroimaging depicted an enhancing lesion along both optic nerves consistent with bilateral optic nerve sheath meningioma. Neuroophthalmological examination showed inferior cut of visual field bilaterally, more extensive on the left eye. Acuity was 20/20 on both eyes.  Microsurgical resection of the tumor was performed through left supraorbital craniotomy, with the goal of eliminating intracranial extension and stabilizing visual function.5 The optic canal was unroofed with diamond bit drill under copious irrigation. A remarkable improvement of her visual field was observed with maintenance of acuity at 20/20 on follow-up. As the patient is attempting pregnancy, she is closely monitored without radiation.  Surgery can be offered as a primary treatment of optic nerve sheath meningiomas, especially in early stages, with likely preservation and, in some cases, improvement of visual function.6  The patient consented to the procedure and the use of image.  Images at 1:46 and 3:48 reprinted from Al-Mefty O, Operative Atlas of Meningiomas. 1998: Raven Press; Philadelphia, PA, with permission from LWW.  Image at 2:57 reprinted from Rassi et al2; © Anil Can, 2018, used with permission.  Image at 9:27 in public domain/age.

2019 ◽  
Vol 236 (04) ◽  
pp. 526-529
Author(s):  
Valeria Kheir ◽  
Mohamed Faouzi ◽  
François-Xavier Borruat

Abstract Background Optic nerve sheath meningioma (ONSM) is a rare benign tumour of the optic nerve sheath that can lead to blindness if untreated. Radiotherapy is commonly accepted as being the treatment of choice. We conducted a retrospective monocentric study to assess the effect of radiotherapy on visual outcomes and tumour control in patients with ONSM. Patients and Methods The charts of all patients affected by ONSM between 1994 and 2016 were reviewed retrospectively. Inclusion criteria were: having been followed by our department, initial visual acuity (VA) better than no light perception, and stereotactic fractionated radiotherapy. VA (Snellen), colour vision (Ishihara), and visual field mean defect (in dB), as well as ONSM size (on MRI) were compared before and after radiotherapy. Visual function was considered improved if two or more criteria improved, stabilised if none or only one criterion changed, and worsened if two or more criteria worsened. The Wilcoxon signed–rank test was used to assess the effect of radiotherapy (significant if p value < 0.05). Results VA improved or stabilised in 13/16 patients (81.25%), with median VA improving from 0.1 logMAR (8/10) to 0 logMAR (10/10) (p value = 0.0134). Colour vision improved or stabilised in 11/15 patients (73.33%), with median results improving from 5/13 to 12/13 (p value = 0.3212). The visual field mean defect improved in 13/15 patients (86.66%), and the median mean defect (MD) improved from 10 dB to 4 dB (p value = 0.0106). The size of the ONSM diminished or stabilised in 100% of our patients. No adverse events of radiotherapy were either reported or detected. Conclusion Fractionated radiotherapy is a safe procedure and may improve visual function in patients with ONSM.


2019 ◽  
Vol 16 (3) ◽  
pp. 62-64
Author(s):  
Bikram Bahadur Thapa ◽  
Sweta Singh ◽  
Rakshya Basnet ◽  
Saurav Piya

A 61-year-old male presented with gradual loss of vision in his right eye for one year at neuro ophthalmology clinic. On clinical examination, his visual acuity was perception of light and intraocular pressure was 12 mm of Hg in right eye. Also, there was relative afferent pupillary defect in the right eye. Fund us examination showed per papillary atrophy, temporal pallor in optic disc with dilated and tortuous optociliary shunt vessels in right eye. Presence of optociliary shunt, visual loss, relative afferent pupillary defect and optic atrophyopt us for further evaluation by visual field and magnetic resonance imaging. Visual field showed unilateral blindness suggesting lesion of optic nerve. Magnetic resonance imaging brain revealed optic nerve sheath meningioma.


2010 ◽  
Vol 41 (02) ◽  
Author(s):  
M Pittner ◽  
G Kammler ◽  
H Zeumer ◽  
A Schulz ◽  
B Kruse ◽  
...  

Author(s):  
Hatice Ferhan Kömürcü ◽  
Gıyas Ayberk ◽  
Ömer Anlar

Introduction: Meningiomas are the third most common intracranial tumors in adults after glial tumors and metastases. Olfactory groove meningiomas often grow without symptoms due to their slow growth rates and location in the frontal lobe. Optic nerve sheath meningiomas are benign neoplasms of the meninges surrounding the optic nerve. The coexistence of olfactory groove and optic nerve sheath meningiomas without any history of neurofibromatosis or radiotherapy has never been reported in the literature. Case Report: A 36-year-old female patient presenting with anosmia, headache, memory disturbance, and visual impairment and operated with the diagnosis of olfactory groove meningioma was reported. In the postoperative period, optic nerve sheath meningioma was detected in the imaging performed due to the persistence of visual impairment. Conclusion: Olfactory groove and optic nerve sheath meningiomas are rare tumors and can be diagnosed late because they progress slowly. Early diagnosis and treatment may affect the prognosis and morbidity of these patients favorably.


1999 ◽  
Vol 67 (3) ◽  
pp. 408-409 ◽  
Author(s):  
I FAYAZ ◽  
F GENTILI ◽  
I R MACKENZIE

2004 ◽  
Vol 14 (4) ◽  
pp. 209-216 ◽  
Author(s):  
Mubarak Al-Gahtany ◽  
Asis Batacharyia ◽  
Fred Gentili

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sabine Ulrike Vay ◽  
Jan-Michael Werner ◽  
Christoph Kabbasch ◽  
Matthias Schmidt ◽  
Alexander Drzezga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document